Daveen Chopra - Jan 17, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TMTT
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jan 17, 2023
Transactions value $
-$130,893
Form type
4
Date filed
1/17/2023, 05:18 PM
Previous filing
Dec 15, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $181K +4K +21.15% $45.28 22.9K Jan 17, 2023 Direct F1
transaction EW Common Stock Sale -$312K -4K -17.46% $78.00 18.9K Jan 17, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -4K -32.17% $0.00 8.44K Jan 17, 2023 Common Stock 4K $45.28 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.